96 related articles for article (PubMed ID: 16724012)
1. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
Belvederesi L; Bianchi F; Loretelli C; Gagliardini D; Galizia E; Bracci R; Rosati S; Bearzi I; Viel A; Cellerino R; Porfiri E
Eur J Hum Genet; 2006 Jul; 14(7):853-9. PubMed ID: 16724012
[TBL] [Abstract][Full Text] [Related]
2. Novel MLH1 frameshift mutation in an extended hereditary nonpolyposis colorectal cancer family.
Kadiyska TK; Kaneva RP; Nedin DG; Alexandrova AB; Gegova AT; Lalchev SG; Christova T; Mitev VI; Horst J; Bogdanova N; Kremensky IM
World J Gastroenterol; 2006 Dec; 12(48):7848-51. PubMed ID: 17203532
[TBL] [Abstract][Full Text] [Related]
3. Rare single-nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome.
Mirabdolhosseini SM; Yaghoob Taleghani M; Rejali L; Sadeghi H; Fatemi N; Tavallaei M; Famil Meyari A; Saeidi N; Ketabi Moghadam P; Sadeghi A; Asadzadeh Aghdaei H; Zali MR; Nazemalhosseini Mojarad E
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1930. PubMed ID: 37919876
[TBL] [Abstract][Full Text] [Related]
4. Hereditary cancer syndromes as model systems for chemopreventive agent development.
Walcott FL; Patel J; Lubet R; Rodriguez L; Calzone KA
Semin Oncol; 2016 Feb; 43(1):134-145. PubMed ID: 26970132
[TBL] [Abstract][Full Text] [Related]
5. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics.
Arnold S; Buchanan DD; Barker M; Jaskowski L; Walsh MD; Birney G; Woods MO; Hopper JL; Jenkins MA; Brown MA; Tavtigian SV; Goldgar DE; Young JP; Spurdle AB
Hum Mutat; 2009 May; 30(5):757-70. PubMed ID: 19267393
[TBL] [Abstract][Full Text] [Related]
6. Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome.
Abildgaard AB; Stein A; Nielsen SV; Schultz-Knudsen K; Papaleo E; Shrikhande A; Hoffmann ER; Bernstein I; Gerdes AM; Takahashi M; Ishioka C; Lindorff-Larsen K; Hartmann-Petersen R
Elife; 2019 Nov; 8():. PubMed ID: 31697235
[TBL] [Abstract][Full Text] [Related]
7. Structure of the human MLH1 N-terminus: implications for predisposition to Lynch syndrome.
Wu H; Zeng H; Lam R; Tempel W; Kerr ID; Min J
Acta Crystallogr F Struct Biol Commun; 2015 Aug; 71(Pt 8):981-5. PubMed ID: 26249686
[TBL] [Abstract][Full Text] [Related]
8. Classification of MLH1 Missense VUS Using Protein Structure-Based Deep Learning-Ramachandran Plot-Molecular Dynamics Simulations Method.
Tam B; Qin Z; Zhao B; Sinha S; Lei CL; Wang SM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255924
[TBL] [Abstract][Full Text] [Related]
9. Multiplexing mutation rate assessment: determining pathogenicity of Msh2 variants in Saccharomyces cerevisiae.
Ollodart AR; Yeh CC; Miller AW; Shirts BH; Gordon AS; Dunham MJ
Genetics; 2021 Jun; 218(2):. PubMed ID: 33848333
[TBL] [Abstract][Full Text] [Related]
10. Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed.
Hicks S; Wheeler DA; Plon SE; Kimmel M
Hum Mutat; 2011 Jun; 32(6):661-8. PubMed ID: 21480434
[TBL] [Abstract][Full Text] [Related]
11. Pathogenicity classification of missense mutations based on deep generative model.
Bai K; Yang L; Xue J; Zhao L; Hao F
Comput Biol Med; 2024 Mar; 170():107980. PubMed ID: 38242017
[TBL] [Abstract][Full Text] [Related]
12. Functional predictors of pathogenicity of missense
Sándor M; Sahin-Tóth M
Gut; 2023 Oct; ():. PubMed ID: 37857479
[No Abstract] [Full Text] [Related]
13. Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair protein.
Dominguez-Valentin M; Drost M; Therkildsen C; Rambech E; Ehrencrona H; Angleys M; Lau Hansen T; de Wind N; Nilbert M; Juel Rasmussen L
Mol Genet Genomic Med; 2014 Jul; 2(4):352-5. PubMed ID: 25077178
[TBL] [Abstract][Full Text] [Related]
14. A rare MSH2 mutation causes defective binding to hMSH6, normal hMSH2 staining, and loss of hMSH6 at advanced cancer stage.
Loconte DC; Patruno M; Lastella P; Di Gregorio C; Grossi V; Forte G; Ingravallo G; Varvara D; Bagnulo R; Simone C; Resta N; Stella A
Hum Pathol; 2014 Oct; 45(10):2162-7. PubMed ID: 25106712
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome.
Ou J; Rasmussen M; Westers H; Andersen SD; Jager PO; Kooi KA; Niessen RC; Eggen BJ; Nielsen FC; Kleibeuker JH; Sijmons RH; Rasmussen LJ; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):340-50. PubMed ID: 19156873
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repair.
Plotz G; Welsch C; Giron-Monzon L; Friedhoff P; Albrecht M; Piiper A; Biondi RM; Lengauer T; Zeuzem S; Raedle J
Nucleic Acids Res; 2006; 34(22):6574-86. PubMed ID: 17135187
[TBL] [Abstract][Full Text] [Related]
17. MLH3 mutation in endometrial cancer.
Taylor NP; Powell MA; Gibb RK; Rader JS; Huettner PC; Thibodeau SN; Mutch DG; Goodfellow PJ
Cancer Res; 2006 Aug; 66(15):7502-8. PubMed ID: 16885347
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord.
Liu X; Liu Y; Zhang J; Zhang W; Sun YE; Gu X; Ma Z
Brain Res Bull; 2014 Jul; 106():9-16. PubMed ID: 24769228
[TBL] [Abstract][Full Text] [Related]
19. Cdk5 inhibitor roscovitine alleviates neuropathic pain in the dorsal root ganglia by downregulating N-methyl-D-aspartate receptor subunit 2A.
Yang L; Gu X; Zhang W; Zhang J; Ma Z
Neurol Sci; 2014 Sep; 35(9):1365-71. PubMed ID: 24659417
[TBL] [Abstract][Full Text] [Related]
20. Effects of roscovitine, a cell cyclin [correction of cycling]-dependent kinase inhibitor, on intraocular pressure of rabbit and retinal ganglion cell damage.
Kasai H; Imamura T; Tsuruma K; Takahashi Y; Kurasawa T; Hirata H; Shimazawa M; Hara H
Neurosci Lett; 2013 Feb; 535():95-9. PubMed ID: 23274706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
